Neovasc Inc. Free Cash Flow Growth

Free Cash Flow Growth of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Free Cash Flow Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Free Cash Flow Growth for the quarter ending March 31, 2022 was 20.17% (a -44.44% decrease compared to previous quarter)
  • Year-over-year quarterly Free Cash Flow Growth increased by 1653.91%
  • Annual Free Cash Flow Growth for 2021 was 15.39% (a -149.28% decrease from previous year)
  • Annual Free Cash Flow Growth for 2020 was -31.23% (a 79.48% increase from previous year)
  • Annual Free Cash Flow Growth for 2019 was -17.4% (a -120.37% decrease from previous year)
  • Twelve month Free Cash Flow Growth ending March 31, 2022 was 19.69% (a 129.22% increase compared to previous quarter)
  • Twelve month trailing Free Cash Flow Growth decreased by -199.75% year-over-year
Trailing Free Cash Flow Growth for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
19.69% 8.59% -4.35% -19.74%
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Free Cash Flow Growth of Neovasc Inc.

Most recent Free Cash Flow Growthof NVCN including historical data for past 10 years.

Interactive Chart of Free Cash Flow Growth of Neovasc Inc.

Neovasc Inc. Free Cash Flow Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 20.17%
2021 36.3% 19.1% 1.15% -26.53% 15.39%
2020 -20.9% -33.43% -37.67% -9.51% -31.23%
2019 0.61% -22.07% 2.58% -19.63% -17.4%
2018 95.18% -36.35% -31.21% 19.88% 85.43%
2017 -304.29% 63.2% 64.46% 41.26% -629.26%
2016 1014.56% -62.81% -85.8% -190.91% 216.5%
2015 -103.05% -86.83% -299.28% -413.76% -155.08%
2014 -190.27% -133.12% 8.98% 36.44% -65.47%
2013 -162.79% -207.84% -135.21% -71.01% -137.18%
2012 80.18% 67.52% 57.49% 41.53% -7.83%
2011 -404.65% 7.26%

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.